|
Multikinase inhibitors for treating high-risk myelodysplastic syndromes: can this be brought into clinical practice?
|
Oct 2013
|
Expert Rev Hematol
|
myelodysplastic syndromes (MDS)
|
|
Hematopoietic stem cell transplantation for older patients with myelodysplastic syndromes.
|
Oct 2013
|
J Natl Compr Canc Netw
|
myelodysplastic syndromes (MDS)
|
|
Management of the refractory aplastic anemia patient: what are the options?
|
Sep 2013
|
Blood
|
aplastic anemia
|
|
Proposed score for survival of patients with myelodysplastic syndromes.
|
Sep 2013
|
Eur J Clin Invest
|
myelodysplastic syndromes (MDS)
|
|
The impact of age on the diagnosis and therapy of myelodysplastic syndromes: results from a retrospective multicenter analysis in Germany.
|
Sep 2013
|
Eur J Haematol
|
myelodysplastic syndromes (MDS)
|
|
BCOR and BCORL1 mutations in myelodysplastic syndromes and related disorders.
|
Sep 2013
|
Blood
|
myelodysplastic syndromes (MDS)
|
|
The role of splicing factor mutations in the pathogenesis of the myelodysplastic syndromes.
|
Sep 2013
|
Adv Biol Regul
|
myelodysplastic syndromes (MDS)
|
|
Polymorphism of the complement receptor 1 gene correlates with hematological response to eculizumab in patients with paroxysmal nocturnal hemoglobinuria
|
Sep 2013
|
Haematologica
|
paroxysmal nocturnal hemoglobinuria (PNH)
|
|
Allogeneic hematopoietic stem cell transplantation for myelodysplastic syndromes
|
Sep 2013
|
Clin Lymphoma Myeloma Leuk
|
myelodysplastic syndromes (MDS)
|
|
Prognostic factors and risk models in myelodysplastic syndromes
|
Sep 2013
|
Clin Lymphoma Myeloma Leuk
|
myelodysplastic syndromes (MDS)
|
